AI
SGYP

Axiom Investors’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Axiom Investors’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-760,518
Closed -$2.21M – 164
2017
Q3 		$2.21M Sell
760,518
-166,417
-18% -$568K 0.05% 117
2017
Q2 		$4.13M Buy
926,935
+425,913
+85% +$1.76M 0.1% 98
2017
Q1 		$2.33M Buy
+501,022
New +$2.91M 0.06% 112

Other funds holding SGYP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Axiom Investors's SGYP Position: Q4 2017 in Review

Axiom Investors sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2017, closing a stake of 760,518 shares — an estimated $2.21M sold.

Axiom Investors first reported a position in SGYP in Q1 2017 and held it in 3 quarters. The position peaked at $4.13M in Q2 2017. 149 funds tracked by Wall St. Rank hold SGYP as of Q4 2017.

  • Axiom Investors reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2017 after selling out during the quarter.
  • Axiom Investors sold 760,518 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2017, an estimated $2.21M.
  • Axiom Investors first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q1 2017 and held it in 3 quarters.
  • Axiom Investors's Synergy Pharmaceuticals, Inc Common Stock position peaked at $4.13M in Q2 2017.
  • 149 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2017.

Based on Axiom Investors's 13F filing for Q4 2017, filed 14 Feb 2018.